Bellerophon Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 18, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Market Capitalization	0	9	29	63	24	47
Market Cap Growth	-	-70.85%	-53.48%	163.68%	-48.91%	-66.97%
Enterprise Value	-4	-2	2	11	14	26
Last Close Price	0.01	0.90	3.10	6.67	5.25	12.02
PE Ratio	-	-	-	-	-	16.71
PB Ratio	0.04	3.39	1.36	1.66	6.69	12.20
P/TBV Ratio	0.04	3.39	1.36	1.66	6.69	12.20
Debt / Equity Ratio	-	0.08	0.04	0.04	0.65	-
Quick Ratio	3.49	1.28	4.90	4.56	1.30	2.21
Current Ratio	3.96	1.40	5.04	4.61	1.37	2.31
Return on Equity (ROE)	-165.96%	-164.21%	-59.32%	-118.20%	-356.30%	445.96%
Return on Assets (ROA)	-78.47%	-80.40%	-32.01%	-51.85%	-69.41%	-63.17%
Return on Invested Capital (ROIC)	-119.52%	-110.57%	-39.51%	-71.69%	-223.69%	-2761.49%
Earnings Yield	-6944.96%	-230.84%	-60.25%	-39.03%	-55.22%	5.98%
FCF Yield	-	-206.85%	-77.44%	-31.39%	-53.84%	-32.95%
Buyback Yield / Dilution	-16.43%	-0.51%	-21.88%	-73.14%	-3.85%	-67.00%
Total Shareholder Return	-16.43%	-0.51%	-21.88%	-73.14%	-3.85%	-67.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.